🇺🇸 FDA
Pipeline program

talampanel

IXL-202-18-189

Phase 2 small_molecule completed

Quick answer

talampanel for Dyskinesias is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Dyskinesias
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials